Home

Press Releases

Brownback Bill Threatens Major Medical Advances
Mar 5 2002
BIO to Testify at House Hearing on User Fee Reauthorization
Mar 5 2002
CMS ISSUES SMALLER REDUCTION IN OPPS PASS-THROUGH PAYMENTS
Mar 4 2002
BIO Appears in Fortune Special Section on Biotechnology
Mar 4 2002
BIO Names Genentech’s Susan Desmond-Hellmann to Board
Feb 28 2002
BIO Names Amgen’s Dennis Fenton to Board
Feb 28 2002
John Davidson, Tom Von Essen Featured Speakers for BIO 2002
Feb 27 2002
MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlight of Events for Friday, February 22, 2002
Feb 22 2002
MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlights for Thursday, February 21, 2002
Feb 21 2002
Two Companies Awarded 2002 Helix Award for Corporate Excellence
Feb 21 2002
BIO Statement on NAS Report on Transgenic Plants
Feb 21 2002
MEDIA ADVISORY --- BIO CEO & Investor Conference 2002: Highlights for Wednesday, February 20, 2002
Feb 20 2002
BIO, E&Y Lead Private Sector Initiative to Provide Biotechnology Resources for the Federal Judiciary
Feb 20 2002
2002 Helix Award to be Presented at BIO CEO & Investor Conference
Feb 15 2002
Industry Experts Announced for BIO’s Investor Conference
Feb 14 2002
Nobel, Pulitzer Prize Winners To Address Biotech Conference in New York
Feb 13 2002
Christopher Reeve to Speak at BIO’s CEO & Investor Conference
Feb 12 2002
Proposed Hike in User Fees Unfair Burden for Biotech Companies
Feb 8 2002
BIO CEO & Investor Conference 2002 Spotlights Industry Leaders
Feb 5 2002
FDA Approves 16 New Biotech Products, Eight New Indications in 2001
Feb 4 2002
BIO 2002 Media Registration Opens
Jan 30 2002
BIO Supports NAS Findings
Jan 18 2002
CMS Delays OPPS Payment Cuts For Breakthrough Medicines
Dec 19 2001
Bipartisan Congressional Letter Urges CMS To Delay Implementation of OPPS Reduction
Dec 13 2001
BIO Names Philadelphia Host City for BIO 2005
Dec 12 2001